Stock report · Delisted · Nasdaq
icad inc (ICAD)
3.73USD Delisted Final close · Jul 15, 2025
ICAD no longer trades. icad inc was delisted from the Nasdaq in July 2025.
All prices on this page are historical. The last trade was on July 15, 2025, at $3.73.
ICAD stock price history
Final trading statistics
- Final close
- $3.73
- Final trading day
- Jul 15, 2025
- Market cap at delisting
- $102.47M
- Shares outstanding
- 27.47M
- Final 52-week range
- $1.19 – $4.01
- Avg. volume (final 3 mo.)
- 780,789
- All-time high
- $135.00 · Apr 1987
- All-time low
- $1.14 · May 2023
- Return since IPO
- -90.7%
- Beta
- 1.40
- Book value / share
- $1.13
- Price / book
- 3.29
About icad inc
iCAD, Inc. offered AI-based cancer detection tools in the United States. Its ProFound Breast Health Suite helped detect breast cancer, assess breast density, estimate one- or two-year cancer risk, and gauge heart risk linked to breast arterial calcifications.
Its Detection products used AI and image analysis to spot cancers earlier, and it sold upgradeable computer-aided detection systems for breast tomosynthesis, digital mammography, MRI and CT. Risk and density tools worked from 2D or 3D mammogram images, and density reporting was standardized by analyzing breast anatomy algorithmically.
Known as Howtek, Inc. until June 2002, the company was incorporated in 1984 and based in Nashua, New Hampshire. Its stock was delisted from the Nasdaq in July 2025, with a final trade on July 15, 2025 at $3.73.
- Exchange (former)
- Nasdaq
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Nashua, NH
- Employees
- 66
- IPO date
- December 3, 1986
- Delisted
- July 15, 2025
- SEC CIK
- 749660
icad inc financials before the delisting
The last 5 fiscal years icad inc reported as a public company, fiscal year ending December.
ICAD revenue and net income
ICAD earnings per share
ICAD annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $19.61M | −$5.6M | −$0.21 |
| FY2023 | $17.32M | −$4.8M | −$0.22 |
| FY2022 | $27.94M | −$13.7M | −$0.53 |
| FY2021 | $33.64M | −$11.2M | −$0.44 |
| FY2020 | $29.70M | −$17.6M | −$0.46 |
Net income is GAAP. EPS is adjusted (non-GAAP) EPS, as reported.
icad inc stock FAQ
What happened to icad inc stock?
icad inc was delisted from the Nasdaq in July 2025. The final close was $3.73 on July 15, 2025.
Can I still buy ICAD stock?
No. ICAD is no longer listed on the Nasdaq or any other U.S. exchange; it was removed on July 15, 2025.
What was the last price of ICAD?
ICAD last closed at $3.73 on July 15, 2025, which valued the company at about $102.47M.
How did icad inc do in its last full fiscal year?
In fiscal 2024, its last full year as a public company, icad inc reported revenue of $19.61M and net income of −$5.6M.
When did icad inc go public?
icad inc shares started trading on December 3, 1986.
ICAD no longer trades, so there is no live quote. The information on this page is for reference only and is not investment advice; see our disclaimer.